Antibody

FANCD2 is one of a number of proteins in the FANC group. It undergoes modification in both its normal and disease state; therefore our FANCD2 antibodies are modified and conjugated in various ways for research.

FANCD2 (Fanconi Anaemia Complementation Group D2) is one of several FANC proteins involved with development of Fanconi Anaemia, a genetic disease that increases cell susceptibility to tumour development. In its normal pathway it interacts with several other genes known to cause cancer, for example BRCA1.

DNA repair processes allow cells to identify and correct lesions in the DNA helix. It is normal for these lesions to happen. Environmental processes such as exposure to UV light and chemicals, as well as day-to-day metabolic changes, can cause hundreds of thousands in a day.

Not everyone knows how antibodies influence animal life, so this article is, in part, a very brief introduction. Novus Biologicals offers a printed version of their Apoptosis Catalog that contains additional information on apoptotic mechanisms; email promotions@novusbio.com to get a copy.

We have seen that antibody research can deliver progress in areas where other methods have not enjoyed such success.

Autism is a condition which demands more research - even if some autistic people do not want their condition to be ‘cured’, most would like some of their symptoms to be alleviated.

Fatemi and colleagues (J Autism Dev Disord. 2009, 39(2) pp. 223–230) subjected brain tissue from autistic and control subjects to SDS-PAGE followed by Western blotting and incubation with antibodies to four GABA-A receptor subunits.

Researchers can manipulate antibodies to yield very impressive research outcomes, which may prove highly relevant to the medical treatment of the future.

Severson et al (MBC 2009, 20(7) pp. 1916-1925) used antibodies, including monoclonal rabbit anti-JAM-A and monoclonal rabbit anti-β1 integrin from Novus Biologicals to investigate epithelial cell migration.

Researchers requiring antibody products can have some difficulty in obtaining precisely what they need. However, recent developments may make this dilemma less of an issue than it has proven in the past.

Antibodies to beclin 1 may help elucidate the significance of this protein and its role in autophagy.

Autophagy is the lysosomal degradation of cell constituents. It occurs in malnutrition, enabling the body to recycle cell components to provide metabolic precursors. Autophagy is also involved in the response to pathogens and in other processes. Some aspects are summarised here.

Treating cancer is a major health priority in western society. Coupled with attempts to alter unhealthy behaviour, it is hoped that better cancer treatment can reduce premature deaths.

Anti-APE1 mouse monoclonal antibodies from Novus Biologicals were antibodies used to investigate drug resistance in non-small cell lung carcinoma (Wang et al., Lung Cancer 2009, 65(3), pp. 298-304). Tumour drug resistance results in less successful chemotherapy.

Anti-AGE antibodies are not the elixir of youth as their name might imply! They have nevertheless provided new information about Alzheimer’s disease, the major cause of dementia in old age.